The launch of universal mRNA influenza vaccine in the United States is expected to provide long-term protection without annual vaccination.

[the United States launches a universal mRNA influenza vaccine is expected to provide long-term protection without annual vaccination]. On Monday, the National Institutes of Health (NIH) announced the launch of a universal influenza vaccine based on mRNA technology, and healthy subjects are being recruited for early clinical trials. Scientists hope that the vaccine will protect against multiple flu strains and provide long-term immunity so that people do not have to be vaccinated every year.